Abbott has secured the US FDA approval for its next generation CardioMEMS HERO device, which is designed to support remote heart failure monitoring.

Medtech companies like BlueWind or Medtronic are increasingly investing in neuromodulation to treat urgency urinary incontinence (UUI).

Synergy Spine Solutions has received PMA from the FDA for the Synergy Disc, expanding cervical disc replacement options for US patients.

The proposed IPO could see MiniMed offer 28m shares as the company looks to reach profitability independently of Medtronic.

Thermo Fisher’s LDT offers clinicians’ deeper insight into individual immunosuppressant dosing regimens for organ transplant ...

ENDRA Life Sciences has reported results from a clinical study showing the Taeus Liver device’s high measurement consistency in MASLD.

Allurion has received the FDA clearance for PMA application for its Gastric Balloon System featuring the Allurion Smart Capsule for obesity treatment.

Stryker has launched Synchfix EVT, a flexible syndesmotic fixation device intended to simplify surgical procedures and support ankle stabilisation in patients with syndesmotic disruptions.

Smith+Nephew has signed a distribution agreement with SI-BONE for the iFuse TORQ pelvic fracture fixation portfolio.

Academia Sinica and NTU Hospital have jointly developed PanMETAI, an AI metabolomics platform for pancreatic cancer detection in early stages.

WashU Medicine researchers have developed an Alzheimer’s blood test symptom prediction model that estimates when individuals may begin to show signs of the disease.

Ottobock's investment follows a first-in-human implantation of Blue Arbor's neuromuscular interface system using one of the German company's prosthetics.